Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael S Rogers

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
The New England Journal of Medicine|June 2, 2006
Thalidomide for multiple myelomaJudah Folkman, Michael S Rogers
Frontiers in Bioscience (Landmark Edition)|January 4, 2011
Targeting the anthrax receptors, TEM-8 and CMG-2, for anti-angiogenic therapyLorna M Cryan, Michael S Rogers
Cold Spring Harbor Perspectives in Medicine|November 6, 2012
Common polymorphisms in angiogenesisMichael S Rogers, Robert J D'Amato
Experimental Cell Research|December 3, 2005
The effect of genetic diversity on angiogenesisMichael S Rogers, Robert J D'Amato
Seminars in Reproductive Medicine|January 20, 2026
EndometriosisMichael S Rogers, Megan Kennedy Burns
Cancer Medicine|August 10, 2019
Are 90% of deaths from cancer caused by metastases?Hanna Dillekås, Michael S Rogers, Oddbjørn Straume
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2013
Pomalidomide is strongly antiangiogenic and teratogenic in relevant animal modelsRobert J D'Amato, Suzanne Lentzsch, Michael S Rogers
American Journal of Obstetrics and Gynecology|March 10, 2007
Treatment of suspected fetal macrosomia: a cost-effectiveness analysisDaljit Sahota, Pong M Yuen, Michael S Rogers
BJOG : an International Journal of Obstetrics and Gynaecology|April 22, 2005
Using group-sequential analysis to achieve the optimal sample sizeMichael S Rogers, Allan M Z Chang, Susan Todd
Nature Protocols|October 20, 2007
The mouse cornea micropocket angiogenesis assayMichael S Rogers, Amy E Birsner, Robert J D'Amato
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
The New England Journal of Medicine|June 2, 2006
Thalidomide for multiple myelomaJudah Folkman, Michael S Rogers
Frontiers in Bioscience (Landmark Edition)|January 4, 2011
Targeting the anthrax receptors, TEM-8 and CMG-2, for anti-angiogenic therapyLorna M Cryan, Michael S Rogers
Cold Spring Harbor Perspectives in Medicine|November 6, 2012
Common polymorphisms in angiogenesisMichael S Rogers, Robert J D'Amato
Experimental Cell Research|December 3, 2005
The effect of genetic diversity on angiogenesisMichael S Rogers, Robert J D'Amato
Seminars in Reproductive Medicine|January 20, 2026
EndometriosisMichael S Rogers, Megan Kennedy Burns
Cancer Medicine|August 10, 2019
Are 90% of deaths from cancer caused by metastases?Hanna Dillekås, Michael S Rogers, Oddbjørn Straume
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2013
Pomalidomide is strongly antiangiogenic and teratogenic in relevant animal modelsRobert J D'Amato, Suzanne Lentzsch, Michael S Rogers
American Journal of Obstetrics and Gynecology|March 10, 2007
Treatment of suspected fetal macrosomia: a cost-effectiveness analysisDaljit Sahota, Pong M Yuen, Michael S Rogers
BJOG : an International Journal of Obstetrics and Gynaecology|April 22, 2005
Using group-sequential analysis to achieve the optimal sample sizeMichael S Rogers, Allan M Z Chang, Susan Todd
Nature Protocols|October 20, 2007
The mouse cornea micropocket angiogenesis assayMichael S Rogers, Amy E Birsner, Robert J D'Amato
Pageof 7